Optimal design for nonlinear response models

Optimal Design for Nonlinear Response Models

Volumn , Issue , 2013, Pages 1-369

  Fedorov, Valerii V ^a   Leonov, Sergei L ^b  

^a IQVIA   (United States)

^b ICON PLC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85053945217     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15054     Document Type: Book

References (426)

1. K.M. Abdelbasit and R.L. Plackett. Experimental design for binary data. J. Am. Statist. Assoc., 78:90–98, 1983.
2. M. Abramowitz and I.A. Stegun. Handbook of Mathematical Functions with Formulas, Graphs and Mathematical Tables. Dover, New York, 9th edition, 1972.
3. A. Agresti. Categorical Data Analysis. Wiley, New York, 2nd edition, 2002.
4. M.K. Al-Banna, A.W. Kelman, and B. Whiting. Experimental design and efficient parameter estimation in population pharmacokinetics. J. Pharmacokin. Biopharmaceut., 18(4):347–360, 1990.
5. A. Albert. Regression and the Moore-Penrose Pseudoinverse. Academic Press, New York, 1972.
6. A. Albert and J.A. Anderson. On the existence of maximum likelihood estimates in logistic regression models. Biometrika, 71(1):1–10, 1984.
7. A. Aliev, V. Fedorov, S. Leonov, and B. McHugh. PkStaMp library for optimization of sampling schemes for PK/PD models. In S.M. Ermakov, V.B. Melas, and A.N. Pepelyshev, editors, Proceedings of the 6th St. Petersburg Workshop on Simulation, volume 1, pages 368–374. VVM com Ltd., St. Petersburg, Russia, 2009.
8. A. Aliev, V. Fedorov, S. Leonov, B. McHugh, and M. Magee. PkStaMp library for constructing optimal population designs for PK/PD studies. Comm. Stat. Simul. Comp., 41(6):717–729, 2012.
9. D. Anbar. A stochastic Newton-Raphson method. J. Statist. Plann. Inf., 2:153–163, 1978.
10. T.W. Anderson and J.B. Taylor. Some experimental results on the statistical properties of least squares estimates in control problems. Econo-metrica, 44(6):1289–1302, 1976.
11. G.E. Andrews, R. Askey, and R. Roy. Special Functions. Cambridge University Press, Cambridge, 1999.
12. V.V. Anisimov, V.V. Fedorov, and S.L. Leonov. Optimal design of pharmacokinetic studies described by stochastic differential equations. In J. López-Fidalgo, J.M. Rodriguez-Diaz, and B. Torsney, editors, mODa 8 – Advances in Model-Oriented Design and Analysis, pages 9–16. Physica-Verlag, Heidelberg, 2007.
13. J.R. Ashford and R. R. Sowden. Multi-variate probit analysis. Biometrics, 26:535–546, 1970.
14. A.C. Atkinson. A segmented algorithm for simulated annealing. Statist. Computing, 2(4):221–230, 1992.
15. A.C. Atkinson. Examples of the use of an equivalence theorem in constructing optimum experimental designs for random-effects nonlinear regression models. J. Statist. Plann. Inf., 36:2595–2606, 2008.
16. A.C. Atkinson, K. Chaloner, A.M. Herzberg, and J. Juritz. Optimal experimental designs for properties of a compartmental model. Biometrics, 49:325–337, 1993.
17. A.C. Atkinson and R.D. Cook. D-optimum designs for heteroscedastic linear models. J. Am. Statist. Assoc., 90(429):204–212, 1995.
18. A.C. Atkinson and D.R. Cox. Planning experiments for discriminating between models (with discussion). J. Royal Statist. Soc. B, 36:321–348, 1974.
19. A.C. Atkinson and A. Donev. Optimum Experimental Design. Clarendon Press, Oxford, 1992.
20. A.C. Atkinson and V.V. Fedorov. Optimal design: Experiments for discriminating between several models. Biometrika, 62:289–303, 1974.
21. A.C. Atkinson and V.V. Fedorov. Optimal design: Experiments for discriminating between two rival models. Biometrika, 62:57–70, 1974.
22. A.C. Atkinson and V.V. Fedorov. The optimum design of experiments in the presence of uncontrolled variability and prior information. In Y. Dodge, V.V. Fedorov, and H. Wynn, editors, Optimal Design and Analysis of Experiments, pages 327–344. North-Holland, Amsterdam, 1988.
23. A.C. Atkinson, V.V. Fedorov, A.M. Herzberg, and R. Zhang. Elemental information matrices and optimal experimental design for generalized regression models. J. Statist. Plann. Inf., Early view, http://dx.doi. org/10.1016/j.jspi.2012.09.012, 2012.
24. A.C. Atkinson, R. Tobias, and A. Donev. Optimum Experimental Designs, with SAS. Oxford University Press, 2007.
25. C.L. Atwood. Sequences converging to D-optimal designs of experiments. Ann. Stat., 1:342–352, 1973.
26. M. Avriel. Nonlinear Programming: Analysis and Methods. Dover Publications, Mineola, NY, 2003.
27. D. Azriel, M. Mandel, and Y. Rinott. The treatment versus experimentation dilemma in dose finding studies. J. Statist. Plann. Inf., 141(8):2759–2768, 2011.
28. A.J. Bailer and W.W. Piegorsch. Estimating integrals using quadrature methods with an application in pharmacokinetics. Biometrics, 46(4):1201–1211, 1990.
29. R. A. Bailey. Design of Comparative Experiments. Cambridge University Press, Cambridge, UK, 2008.
30. H. Bandemer, A. Bellmann, W. Jung, Le Anh Son, S. Nagel, W. Näther, J. Pilz, and K. Richter. Theorie and Anwendung der Optimalen Ver-suchsplanung. I. Handbuch zur Theorie. Akademie-Verlag, Berlin, 1977.
31. J. Bartroff and T.L. Lai. Approximate dynamic programming and its application to the design of phase I cancer trials. Statistical Science, 25(2):245–257, 2010.
32. J. Bartroff, T.L. Lai, and M.C. Shih. Sequential Experimentation in Clinical Trials: Design and Analysis, volume 298 of Springer Series in Statistics. Springer, New York, 2013.
33. D.M. Bates and D.G. Watts. Nonlinear Regression Analysis and Its Applications. Wiley, New York, 1988.
34. S. Batsell, V.V. Fedorov, and D. Flanagan. Multivariate prediction: Selection of the most informative components to measure. In A.C. Atkinson, L. Pronzato, and H. Wynn, editors, Proceedings of MODA-5 International Workshop, pages 215–222. Springer-Verlag, New York, 1988.
35. P. Bauer. Adaptive designs: Looking for a needle in the haystack – A new challenge in medical research. Statist. Med., 27(10):1565–1580, 2008.
36. P. Bauer and W. Brannath. The advantages and disadvantages of adaptive designs in clinical trials. Drug Discov. Today, 9:351–357, 2004.
37. R.J. Bauer, S. Guzy, and C. Ng. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples. AAPS J., 9(1):E60–E83, 2007.
38. C. Bazzoli, S. Retout, and F. Mentré. Fisher information matrix for nonlinear mixed effects multiple response models: Evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model. Statist. Med., 28(14):1940–1956, 2009.
39. S.L. Beal and L.B. Sheiner. Heteroscedastic nonlinear regression. Technometrics, 30(3):327–338, 1988.
40. S.L. Beal and L.B. Sheiner. NONMEM User’s Guide. NONMEM Project Group, University of California, San Francisco, 1992.
41. E.F. Beckenbach and Bellman R.E. Inequalities. Springer, Berlin, 1961.
42. B. N. Bekele and Y. Shen. A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial. Biometrics, 61:343–354, 2005.
43. R. Bellman. Introduction to Matrix Analysis. SIAM, Philadelphia, 1995.
44. M.P.F. Berger and W.K. Wong. An Introduction to Optimal Designs for Social and Biomedical Research (Statistics in Practice). Wiley, Chichester, 2009.
45. J.M. Bernardo. Expected information as expected utility. Ann. Statist., 7:686–690, 1979.
46. J.M. Bernardo and A.F.M. Smith. Bayesian Theory. Wiley, New York, 1994.
47. D.A. Berry, P. Müller, A. P. Grieve, M.K. Smith, T. Parke, R. Blazek, N. Mitchard, and M. Krams. Adaptive Bayesian designs for dose-ranging drug trials. In C. Gatsonis, R.E. Kass, B. Carlin, A. Carriquiry, A. Gelman, I. Verdinelli, and M. West, editors, Case Studies in Bayesian Statistics V, volume 162 of Lecture Notes in Statistics, pages 99–181. Springer, New York, 2002.
48. I.O. Bohachevsky, M.E. Johnson, and M.L. Stein. Generalized simulated annealing for function optimization. Technometrics, 28(3):209– 217, 1986.
49. P. Bonate. Pharmacokinetic-Pharmacodynamic Modeling and Simulation. Springer, New York, 2010.
50. B. Bornkamp, F. Bretz, A. Dmitrienko, G. Enas, B. Gaydos, C.-H. Hsu, F. König, M. Krams, Q. Liu, B. Neuenschwander, T. Park, J. Pinheiro, A. Roy, R. Sax, and F. Shen. Innovative approaches for designing and analyzing adaptive dose-ranging trials. J. Biopharm. Statist., 17:965– 995, 2007.
51. G.E.P. Box and W.J. Hill. Discrimination among mechanistic models. Technometrics, 9:327–338, 1967.
52. G.E.P. Box and W.J. Hill. Correcting inhomogeneity of variance with power transformation weighting. Technometrics, 16:385–389, 1974.
53. G.E.P. Box and W.G. Hunter. Sequential design of experiments for nonlinear models. In J.J Korth, editor, Proceedings of IBM Scientific Computing Symposium. IBM, White Plains, NY, 1965.
54. G.E.P. Box and H.L. Lucas. Design of experiments in nonlinear situations. Biometrika, 46:77–90, 1959.
55. A. Bozin and M. Zarrop. Self-tuning extremum optimizer – Convergence and robustness properties. In Proceedings of ECC 91, First European Control Conference, pages 672–677, 1991.
56. T. Braun. The bivariate continual reassessment method: Extending the CRM to phase I trials of two competing outcomes. Controlled Clinical Trials, 23:240–256, 2002.
57. L.D. Brown, I. Olkin, J. Sacks, and Wynn H.P., editors. Jack Kiefer. Collected Papers III. Design of Experiments. Springer, New York, 1985.
58. J.F.C.L. Cadima and I.T. Jolliffe. Variable selection and the interpretation of principal subspaces. J. Agricultural, Biological, and Environmental Statistics, 6:62–79, 2001.
59. S. Cambanis. Sampling designs for time series. In E.J. Hannan, P.R. Krishnaiah, and M.M. Rao, editors, Time Series in the Time Domain. Handbook of Statistics, volume 5, pages 337–362. North-Holland, Amsterdam, 1985.
60. R.J. Carroll and D. Ruppert. Robust estimation in heteroscedastic linear models. Ann. Statist., 10:429–441, 1982.
61. R.J. Carroll and D. Ruppert. Transformation and Weighting in Regression. Chapman & Hall, New York, 1988.
62. W.F. Caselton, L. Kan, and J.V. Zidek. Quality data networks that minimize entropy. In A.T. Walden and P. Guttorp, editors, Statistics in the Environmental and Earth Sciences, pages 10–38. Arnold, London, 1992.
63. W.F. Caselton and J.V. Zidek. Optimal monitoring network designs. Statist. Prob. Lett., 2:223–227, 1984.
64. K. Chaloner. Optimal Bayesian experimental design for linear models. Ann. Statist., 12:283–300, 1984.
65. K. Chaloner and I. Verdinelli. Bayesian experimental design: A review. Statistical Science, 10:273–304, 1995.
66. H.H. Chang and Z. Ying. Nonlinear sequential designs for logistic item response theory models with applications to computerized adaptive tests. Ann. Statist., 37(3):1466–1488, 2009.
67. M. Chang. Adaptive Design Theory and Implementation Using SAS and R. Chapman & Hall/CRC, Boca Raton, FL, 2008.
68. P. Chaudhuri and P.A. Mykland. Nonlinear experiments: Optimal design and inference based on likelihood. J. Am. Stat. Assoc., 88:538–546, 1993.
69. P. Chaudhuri and P.A. Mykland. On efficient designing of nonlinear experiments. Statistica Sinica, 5:421–440, 1995.
70. H. Chernoff. Locally optimal designs for estimating parameters. Ann. Math. Statist., 24:586–602, 1953.
71. H. Chernoff. Sequential Analysis and Optimal Design. SIAM, Philadelphia, 1972.
72. Y.K. Cheung. Stochastic approximation and modern model-based designs for dose-finding clinical trials. Statistical Science, 25(2):191–201, 2010.
73. Y.K. Cheung. Dose Finding by the Continual Reassessment Method. Chapman & Hall/CRC, Boca Raton, FL, 2011.
74. S. Chevret, editor. Statistical Methods for Dose-Finding Experiments. Wiley, New York, 2006.
75. S. Chib and Greenberg E. Analysis of multivariate probit models. Biometrika, 85:347–361, 1998.
76. W.L. Chiou. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokinet. Biopharm., 6(6):539–546, 1978.
77. W.G. Cochran. Experiments for nonlinear functions (R.A. Fisher Memorial Lecture). J. Am. Stat. Assoc., 68:771–781, 1973.
78. R.D. Cook. Influential observations in linear regression. J. Am. Stat. Assoc., 74(365):169–174, 1979.
79. R.D. Cook and V.V. Fedorov. Constrained optimization of experimental design. Statistics, 26:129–178, 1995.
80. R.D. Cook and W.K. Wong. On the equivalence of constrained and compound optimal designs. J. Am. Stat. Assoc., 89(426):687–692, 1994.
81. T.M. Cover and J.A. Thomas. Elements of Information Theory. Wiley, New York, 1991.
82. D.R. Cox. The Analysis of Binary Data. Chapman & Hall, London, 1970.
83. H. Cramèr. Mathematical Methods of Statistics. Princeton University Press, Princeton, NJ, 1946.
84. J.S. Cramer. Logit Models from Economics and Other Fields. Cambridge University Press, Cambridge, 2003.
85. O. Cureton and D. D’Agostino. Factor Analysis: An Applied Approach. Lawrence Erlbaum, Hillsdale, NY, 1983.
86. D.Z. D’Argenio. Optimal sampling times for pharmacokinetic experiments. J. Pharmacokin. Biopharmaceut., 9(6):739–756, 1981.
87. D.Z. D’Argenio. Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments. Math. Biosci., 99:105–118, 1990.
88. D.Z. D’Argenio, A. Schumitzky, and X. Wang. ADAPT 5 User’s Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. Biomedical Simulations Resource, University of Southern California, Los Angeles, 2009.
89. M. Davidian and R.J. Carroll. Variance function estimation. J. Am. Stat. Assoc., 82:1079–1091, 1987.
90. M. Davidian and D.M. Giltinan. Nonlinear Models for Repeated Measurement Data. Chapman & Hall, London, 1995.
91. A. de la Garza. Spacing of information in polynomial regression. Ann. Math. Statist., 25:123–130, 1954.
92. B. Delyon, M. Lavielle, and E. Moulines. Convergence of a stochastic approximation version of the EM algorithm. Ann. Statist., 27(1):94–128, 1999.
93. E. Demidenko. Mixed Models. Theory and Application. Wiley, Hoboken, NJ, 2004.
94. C. Derman. Non-parametric up-and-down experimentation. Ann. Math. Statist., 28:795–798, 1957.
95. H. Dette and V.B. Melas. A note on the de la Garza phenomenon for locally optimal designs. Ann. Statist., 39(2):1266–1281, 2011.
96. H. Dette, A. Pepelyshev, and T. Holland-Letz. Optimal designs for random effect models with correlated errors with applications in population pharmacokinetics. Ann. Appl. Statist., 4(3):1430–1450, 2010.
97. H. Dette, A. Pepelyshev, and A. Zhigljavsky. Improving updating rules in multiplicative algorithms for computing D-optimal designs. Comput. Statist. Data Anal., 53:312–320, 2008.
98. H. Dette and W.K. Wong. Optimal designs when the variance is a function of the mean. Biometrics, 55:925–929, 1999.
99. W.J. Dixon and A.M. Mood. A method for obtaining and analyzing sensitivity data. J. Am. Statist. Assoc., 13(1):109–126, 1948.
100. D.J. Downing, V.V. Fedorov, and S.L. Leonov. Extracting information from the variance function: Optimal design. In A.C. Atkinson, P. Hackl, and W.G. Müller, editors, mODa6 – Advances in Model-Oriented Design and Analysis, pages 45–52. Physica-Verlag, Heidelberg, 2001.
101. V. Dragalin and V.V. Fedorov. Adaptive designs for dose-finding based on efficacy-toxicity response. J. Stat. Plann. Inf., 136:1800–1823, 2006.
102. V. Dragalin, V.V. Fedorov, and Y. Wu. Optimal designs for bivariate probit model. BDS Technical Report 2006-01. GlaxoSmithKline Pharmaceuticals, 2006.
103. V. Dragalin, V.V. Fedorov, and Y. Wu. Adaptive designs for selecting drug combinations based on efficacy-toxicity response. J. Stat. Plann. Inf., 138(2):352–373, 2008.
104. max model. J. Biopharm. Statist., 18:1051–1070, 2007.
105. N.R. Draper and W.G. Hunter. The use of prior distributions in the design of experiments for parameter estimation in non-linear situations. Biometrika, 54:147–153, 1967.
106. N.R. Draper and H. Smith. Applied Regression Analysis. Wiley, New York, 3rd edition, 1998.
107. S.B. Duffull, S. Retout, and F. Mentré. The use of simulated annealing for finding optimal population designs. Comput. Methods Programs Biomed., 69:25–35, 2002.
108. S.B. Duffull, T.H. Waterhouse, and J.A. Eccleston. Some considerations on the design of population pharmacokinetic studies. J. Pharmacokin. Pharmacodyn., 32:441–457, 2005.
109. V. Dupa and U. Herkenrath. Stochastic approximation on a discrete set and the multi-armed bandit problem. Comm. Statist. Sequential Analysis, 1(1):1–25, 2007.
110. S.D. Durham and N. Flournoy. Random walks for quantile estimation. In S.S. Gupta and J.O. Berger, editors, Statistical Decision Theory and Related Topics, V, pages 467–476. Springer, New York, 1994.
111. S.D. Durham and N. Flournoy. Up-and-down designs I: Stationary treatment distributions. In N. Flournoy and W.F. Rosenberger, editors, Adaptive Designs, volume 25 of IMS Lecture Notes-Monograph Series, pages 139–157. Institute of Mathematical Statistics, Hayward, CA, 1995.
112. S.D. Durham, N. Flournoy, and W. Li. A sequential design for maximizing the probability of a favourable response. Canad. J. Statist., 26(3):479–495, 1998.
113. O. Dykstra. The augmentation of experimental data to maximize X, X. Technometrics, 13:682–688, 1971.
114. G. Elfving. Optimum allocation in linear regression theory. Ann. Math. Statist., 23:255–262, 1952.
115. S.M. Ermakov, editor. Mathematical Theory of Experimental Design. Nauka, Moscow, 1983.
116. S.M. Ermakov and A.A. Zhigljavsky. Mathematical Theory of Optimal Experiment. Nauka, Moscow, 1987.
117. E.I. Ette, A.W. Kelman, C.A. Howie, and B. Whiting. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters. Ann. Pharmacotherapy, 27:1034–1039, 1993.
118. E.I. Ette, A.W. Kelman, C.A. Howie, and B. Whiting. Analysis of animal pharmacokinetic data: Performance of the one point per animal design. J. Pharmacokin. Biopharmaceut., 23(6):551–566, 1995.
119. E.I. Ette, H. Sun, and T.M. Ludden. Balanced designs in longitudinal population pharmacokinetic studies. J. Clin. Pharmacol., 38:417–423, 1998.
120. J.W. Evans. Computer augmentation of experimental data to maximize X, X. Technometrics, 21:321–330, 1979.
121. M. Evans and T. Swartz. Approximating Integrals via Monte Carlo and Deterministic Methods. Oxford University Press, Oxford, 2000.
122. S.K. Fan and K. Chaloner. Optimal design for a continuation-ratio model. In A.C. Atkinson, P. Hackl, and W.G. Müller, editors, mODa6 – Advances in Model-Oriented Design and Analysis, pages 77–85. Physica-Verlag, Heidelberg, 2001.
123. D. Faries. Practical modification of the continual reassessment method for phase I cancer clinical trials. J. Biopharm. Statist., 4:147–164, 1994.
124. FDA. Adaptive Design Clinical Trials for Drugs and Biolog-ics, Draft Guidance. FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM201790.pdf, 2010.
125. V.V. Fedorov. Theory of Optimal Experiment. Moscow University Press, Moscow (in Russian), 1969.
126. V.V. Fedorov. The design of experiments in the multiresponse case. Theory Probab. Appl., 16:323–332, 1971.
127. V.V. Fedorov. Theory of Optimal Experiment. Academic Press, New York, 1972.
128. V.V. Fedorov. Regression problems with controllable variables subject to error. Biometrika, 61:49–56, 1974.
129. V.V. Fedorov. Parameter estimation for multivariate regression. In V. Nalimov, editor, Regression Experiments (Design and Analysis), pages 112–122. Moscow Universtiy Press, Moscow, 1977.
130. V.V. Fedorov. Design of model testing experiments. In Symposia Matematica, volume XXV, pages 171–180. Instituto Nazionale Di Alta Matematica, 1981.
131. V.V. Fedorov. Design of spatial experiments: model fitting and prediction. In S. Ghosh and C.R. Rao, editors, Design and Analysis of Experiments, volume 13 of Handbook of Statistics, pages 515–553. Elsevier, North Holland, 1996.
132. V.V. Fedorov, N. Flournoy, Y. Wu, and R. Zhang. Best intention designs in dose-finding studies. Preprint NI11065-DAE, http://www.newton. ac.uk/preprints/NI11065.pdf. Isaac Newton Institute for Mathematical Sciences, Cambridge, UK, 2011.
133. V.V. Fedorov, R. Gagnon, S. Leonov, and Y. Wu. Optimal design of experiments in pharmaceutical applications. In A. Dmitrienko, C. Chuang-Stein, and R. D’Agostino, editors, Pharmaceutical Statistics Using SAS. A Practical Guide, pages 151–195. SAS Press, Cary, NC, 2007.
134. V.V. Fedorov, R. Gagnon, and S.L. Leonov. Design of experiments with unknown parameters in variance. Appl. Stoch. Models Bus. Ind., 18:207–218, 2002.
135. V.V. Fedorov and P. Hackl. Model-Oriented Design of Experiments. Springer, New York, 1997.
136. V.V. Fedorov, P. Hackl, and W. Müller. Estimation and experimental design for second kind regression models. Inform. Biom. Epidem. Med. Biol., 24(3):134–151, 1993.
137. V.V. Fedorov, A.M. Herzberg, and S.L. Leonov. Component-wise dimension reduction. J. Stat. Plann. Inf., 114:81–93, 2003.
138. V.V. Fedorov, A.M. Herzberg, and S.L. Leonov. Methods of selecting informative variables. Biometrical J., 48(1):157–173, 2006.
139. V.V. Fedorov and B. Jones. The design of multicentre trials. Statist. Meth. Med. Res., 14(3):205–48, 2005.
140. V.V. Fedorov and V. Khabarov. Duality of optimal designs for model discrimination and parameter estimation. Biometrika, 73:183–190, 1986.
141. V.V. Fedorov and S.L. Leonov. Optimal design of dose-response experiments: A model-oriented approach. Drug Inf. J., 35(4):1373–1383, 2001.
142. V.V. Fedorov and S.L. Leonov. Optimal designs for regression models with forced measurements at baseline. In A. Di Bucchianico, H. Läuter, and H. Wynn, editors, mODa 7 – Advances in Model-Oriented Design and Analysis, pages 61–69. Physica-Verlag, Heidelberg, 2004.
143. V.V. Fedorov and S.L. Leonov. Parameter estimation for models with unknown parameters in variance. Comm. Statist. Theory Meth., 33(11):2627–2657, 2004.
144. V.V. Fedorov and S.L. Leonov. Response driven designs in drug development. In W.K. Wong and M.P.F. Berger, editors, Applied Optimal Designs, pages 103–136. Wiley, Chichester, 2005.
145. V.V. Fedorov and S.L. Leonov. Estimation of population PK measures: Selection of sampling grids. BDS Technical Report 2006-02. Glaxo-SmithKline Pharmaceuticals, 2006.
146. V.V. Fedorov and S.L. Leonov. Population pharmacokinetic measures, their estimation and selection of sampling times. J. Biopharm. Statist., 17(5):919–941, 2007.
147. V.V. Fedorov, S.L. Leonov, and V.A. Vasiliev. Pharmacokinetic studies described by stochastic differential equations: Optimal design for systems with positive trajectories. In A. Giovagnoli, A.C. Atkinson, and B. Torsney, editors, mODa 9 – Advances in Model-Oriented Design and Analysis, pages 73–80. Physica-Verlag/Springer, Berlin, 2010.
148. V.V. Fedorov and M.B. Malyutov. Optimal designs in regression problems. Math. Operat. Statist., 3:281–308, 1972.
149. V.V. Fedorov and W. Müller. Comparison of two approaches in the optimal design of an observation network. Statistics, 20(3):339–351, 1989.
150. V.V. Fedorov and A. Pázman. Design of physical experiments (statisti-cal methods). Fortschritte der Physik, 24:325–345, 1968.
151. V.V. Fedorov and A.B. Uspensky. Numerical Aspects of Design and Analysis of Regression Experiments. Moscow State University Press, Moscow, 1975.
152. V.V. Fedorov and Y. Wu. Dose finding designs for continuous responses and binary utility. J. Biopharm. Statist., 17(6):1085–1096, 2007.
153. V.V. Fedorov, Y. Wu, and R. Zhang. Optimal dose-finding designs with correlated continuous and discrete responses. Statist. Med., 31(3):217– 234, 2012.
154. J. Fellman. On the allocation of linear observations. Soc. Sci. Fenn. Comment. Phys.-Math., 44:27–78, 1974.
155. D.J. Finney. Probit Analysis. Cambridge University Press, Cambridge, 1971.
156. D.J. Finney. Radioligand assay. Biometrics, 32:721–740, 1976.
157. R.A. Fisher. The Design of Experiments. Hafner, Ney York, 8th edition, 1971.
158. N. Flournoy. A clinical experiment in bone marrow transplantation: Estimating a percentage point of a quantal response curve. In C. C. Gatsonis, J.S. Hodges, R.E. Kass, and N.D. Singpurwala, editors, Case Studies in Bayesian Statistics, pages 324–336. Springer-Verlag, New York., 1993.
159. N. Flournoy, W.F. Rosenberger, and W.K. Wong, editors. New Developments and Applications in Experimental Design, volume 34 of IMS Lecture Notes-Monograph Series. Institute of Mathematical Statistics, Hayward, CA, 1998.
160. B. Flury. Common Principal Components and Related Multivariate Models. Wiley, New York, 1988.
161. I. Ford and S.D. Silvey. A sequentially constructed design for estimating a nonlinear parametric function. Biometrika, 67(2):381–388, 1980.
162. I. Ford, B. Torsney, and C.F.J. Wu. The use of a canonical form in the construction of locally-optimal designs for nonlinear problems. J. Roy. Statist. Soc. B, 54:569–583, 1992.
163. G.E. Forsythe, M.A. Malcolm, and C.B. Moler. Computer Methods for Mathematical Computations. Prentice Hall, Englewood Cliffs, NJ, 1976.
164. D. Fuller and W. Scherer. The desirability function: Underlying assumptions and application implications. In Proceedings of 1998 IEEE International Conference on Systems, Man, and Cybernetics, volume 4, pages 4016–4021. IEEE, 1998.
165. J. Gabrielsson and D. Weiner. Pharmacokinetic and Pharmacodynamic Data Analysis, Concepts and Applications. Swedish Pharmaceutical Press, Stockholm, 3rd edition, 2001.
166. N. Gaffke and R. Mathar. On a class of algorithms from experimental design. Optimization, 24:91–126, 1992.
167. R. Gagnon and S. Leonov. Optimal population designs for PK models with serial sampling. J. Biopharm. Statist., 15(1):143–163, 2005.
168. R. Gagnon and J.J. Peterson. Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data. J. Pharmacokinet. Biopharm., 26(1):87–102, 1998.
169. P. Gallo, C. Chuang-Stein, V. Dragalin, B. Gaydos, M. Krams, and J. Pinheiro. Adaptive designs in clinical drug development – An executive summary of the PhRMA Working Group. J. Biopharm. Statist., 16(3):143–163, 2006.
170. C.W. Gardiner. Handbook of Stochastic Methods for Physics, Chemistry and the Natural Sciences. Springer, Berlin, 3rd edition, 2003.
171. E. Garrett-Mayer. The continual reassessment method for dose-finding studies: A tutorial. Clin. Trials, 3:57–71, 2006.
172. B. Gaydos, K.M. Anderson, D. Berry, N. Burnham, C. Chuang-Stein, J. Dudinak, P. Fardipour, P. Gallo, S. Givens, R. Lewis, J. Maca, J. Pinheiro, Y. Pritchett, and M. Krams. Good practices for adaptive clinical trials in pharmaceutical product development. Drug Inf. J., 43:539–556, 2009.
173. M. Gezmu and N. Flournoy. Group up-and-down designs for dose-finding. J. Statist. Plann. Inf., 136(6):1749–1764, 2006.
174. M. Ghosh, N. Mukhopadhyay, and P.K. Sen. Sequential Estimation. Wiley, New York, 1997.
175. M. Gibaldi. Biopharmaceutics and Clinical Pharmacokinetics. Lea & Febiger, Philadelphia, PA, 1984.
176. M. Gibaldi and D. Perrier. Pharmacokinetics. Marcel Dekker, New York, 2nd edition, 1971.
177. J. Gladitz and J. Pilz. Construction of optimal designs in random coefficient regression models. Statistics, 13:371–385, 1982.
178. S.N. Goodman, M.L. Zahurak, and S. Piantadosi. Some practical improvements in the continual reassessment method for phase I studies. Statist. Med., 14:1149–1161, 1995.
179. T.A. Gooley, P.J. Martin, D.F. Lloyd, and M. Pettinger. Simulation as a design tool for phase I/II clinical trials: An example from bone marrow transplantation. Controlled Clinical Trials, 15:450–460, 1994.
180. P. Goos and B. Jones. Optimal Design of Experiments: A Case Study Approach. Wiley, New York, 2011.
181. I.S. Gradshteyn and I.M. Ryzhik. Table of Integrals, Series, and Products. Academic Press, San Diego, 5th edition, 1994.
182. G. Graham and L. Aarons. Optimum blood sampling windows for parameter estimation in population pharmacokinetic experiments. Statist. Med., 25:4004–4019, 2006.
183. I. Gueorguieva, K. Ogungbenro, G. Graham, S. Glatt, and L. Aarons. A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models. Comput. Methods Programs Biomed., 86:51–61, 2007.
184. P.G. Guest. The spacing of observations in polynomial regression. Ann. Math. Statist., 29:294–299, 1958.
185. P. Guttorp, N.D. Le, P.D. Sampson, and J.V. Zidek. Using entropy in the redesign of an environmental monitoring network. In G. P. Patil and C.R. Rao, editors, Multivariate Environmental Statistics, pages 173–202. North Holland, Amsterdam, 1993.
186. L.M. Haines. The application of the annealing algorithm to the construction of exact optimal designs for linear-regression models. Technometrics, 29(4):439–447, 1987.
187. L.M. Haines, I. Perevozskaya, and W.F. Rosenberger. Bayesian optimal designs for phase I clinical trials. Biometrics, 59:561–570, 2003.
188. M. Hamada, H.F. Martz, C.S. Reese, and A.G. Wilson. Finding near-optimal Bayesian experimental designs via genetic algorithms. Am. Statistician, 55(3):175–181, 2001.
189. C. Han and K. Chaloner. Bayesian experimental design for nonlinear mixed-effects models with application to HIV dynamics. Biometrics, 60:25–33, 2004.
190. C. Han, K. Chaloner, and A.S. Perelson. Bayesian analysis of a population HIV dynamic model. In C. Gatsonis, A. Carriquiry, A. Gelman, D. Higdon, R. Kass, D. Pauler, and I. Verdinelli, editors, Case Studies in Bayesian Statistics, volume VI, pages 223–237. New York, Springer, 2002.
191. J.W. Hardin and J.M. Hilbe. Generalized Estimating Equations. Chapman & Hall, Boca Raton, FL, 2003.
192. J. Hardwick, M.C. Meyer, and Q.F. Stout. Directed walk designs for dose-response problems with competing failure modes. Biometrics, 59:229–236, 2003.
193. J. Hardwick and Q.F. Stout. Optimizing a unimodal response function for binary variables. In A.C. Atkinson, B. Bogacka, and A. Zhigljavsky, editors, Optimum Design 2000, pages 195–208. Kluwer, Dordrecht, 2001.
194. R. Harman and L. Pronzato. Improvements on removing nonoptimal support points in D-optimum design algorithms. Statist. Probab. Lett., 77:90–94, 2007.
195. D.A. Harville. Matrix Algebra From a Statistician’s Perspective. Springer, New York, 1997.
196. R. Haycroft, L. Pronzato, H.P. Wynn, and A.A. Zhigljavsky. Studying convergence of gradient algorithm via optimal experimental design theory. In L. Pronzato and A.A. Zhigljavsky, editors, Optimal Design and Related Areas in Optimization and Statistics, volume 28 of Springer Optimization and Its Applications, pages 13–37. Springer, New York, 2009.
197. A.S. Hedayat, B. Yan, and J.M. Pezutto. Modeling and identifying optimum designs for fitting dose response curves based on raw optical data. J. Am. Statist. Assoc., 92:1132–1140, 1997.
198. M.A. Heise and R.H. Myers. Modeling and identifying optimum designs for fitting dose response curves based on raw optical data. Biometrics, 52:613–624, 1996.
199. C.C. Heyde. Quasi-Likelihood and Its Applications. Springer, New York, 1997.
200. P.D.H. Hill. D-optimal designs for partially nonlinear regression models. Technometrics, 22:275–276, 1980.
201. P.G. Hoel. Efficiency problems in polynomial estimation. Ann. Math. Statist., 29:1134–1145, 1958.
202. P.G. Hoel. Asymptotic efficiency in polynomial estimation. Ann. Math. Statist., 32:1042–1047, 1961.
203. P.G. Hoel. Minimax designs in two dimensional regression. Ann. Math. Statist., 36:1097–1106, 1965.
204. P.G. Hoel. Optimum designs for polynomial extrapolation. Ann. Math. Statist., 36:1483–1493, 1965.
205. T. Holland-Letz, H. Dette, and D. Renard. Efficient algorithms for optimal designs with correlated observations in pharmacokinetics and dose-finding studies. Biometrics, 68(1):138–145, 2012.
206. D.W. Hosmer and S. Lemeshow. Applied Logistic Regression. Wiley, New York, 2000.
207. I. Hu. On sequential designs in nonlinear problems. Biometrika, 85:496– 503, 1998.
208. S. Huet, A. Bouvier, M.-A. Poursat, and E. Jolivet. Statistical Tools for Nonlinear Regression. A Practical Guide with S-PLUS and R examples. Springer, New York, 2000.
209. A. Ivanova. A new dose-finding design for bivariate outcomes. Biometrics, 59:1001–1007, 2003.
210. A. Ivanova, C. Xiao, and Y. Tymofyeyev. Two-stage designs for phase 2 dose-finding trials. Statist. Med., 31(24):1001–1007, 2012.
211. C. Jennison and B.W. Turnbull. Group Sequential Methods with Applications to Clinical Trials. Chapman & Hall, Boca Raton, FL, 2000.
212. R.I. Jennrich. Asymptotic properties of nonlinear least squares estimators. Ann. Math. Statist., 40:633–643, 1969.
213. R.I. Jennrich and M.D. Schluchter. Unbalanced repeated-measures models with structured covariance matrices. Biometrics, 42:805–820, 1986.
214. R. Jin, W. Chen, and A. Sudjianto. An efficient algorithm for constructing optimal design of computer experiments. J. Stat. Plann. Inf., 134:268–287, 2005.
215. J.D. Jobson and W.A. Fuller. Least squares estimation when the covariance matrix and parameter vector are functionally related. J. Am. Stat. Assoc., 75:176–181, 1980.
216. M.E. Johnson and C.J. Nachtsheim. Some guidelines for constructing exact D-optimal designs on convex design spaces. Technometrics, 25:271–277, 1983.
217. N.L. Johnson, A.W. Kemp, and N. Balakrishnan. Univariate Discrete Distributions. Wiley, New York, 3rd edition, 2005.
218. N.L. Johnson, S. Kotz, and N. Balakrishnan. Continuous Univariate Distributions – 1. Wiley, New York, 2nd edition, 1994.
219. N.L. Johnson, S. Kotz, and N. Balakrishnan. Continuous Univariate Distributions – 2. Wiley, New York, 2nd edition, 1995.
220. N.L. Johnson, S. Kotz, and N. Balakrishnan. Discrete Multivariate Distributions. Wiley, New York, 1997.
221. I.T. Jolliffe. Principal Component Analysis. Springer-Verlag, New York, 2nd edition, 2002.
222. S.A. Julious and C.A.M. Debarnot. Why are pharmacokinetic data summarized by arithmetic means? J. Biopharm. Statist., 10(1):55–71, 2000.
223. L.A. Kalish and J.L. Rosenberger. Optimal designs for the estimation of the logistic function. Technical Report 33, Penn State University, University Park, PA, 1978.
224. A. Källén and P. Larsson. Dose response studies: How do we make them conclusive? Statist. Med., 18:629–641, 1999.
225. S. Karlin and W. Studden. Tchebysheff Systems: With Applications in Analysis and Statisticss. Wiley, New York, 1966.
226. K.F. Karpinski. Optimality assessment in the enzyme-linked im-munosorbent assay (ELISA). Biometrics, 46:381–390, 1990.
227. A.I. Khuri. A note on D-optimal designs for partially nonlinear regression models. Technometrics, 26(1):59–61, 1984.
228. J. Kiefer. Optimum experimental designs V, with applications to systematic and rotable designs. In Proc. Fourth Berkeley Symp., volume 1, pages 381–405. University of California Press, Berkeley, CA, 1961.
229. J. Kiefer. General equivalence theory for optimum designs (approximate theory). Ann. Statist., 22:849–879, 1974.
230. J. Kiefer and J. Wolfowitz. Stochastic estimation of the maximum of a regression function. Ann. Math. Statist., 23:462–466, 1952.
231. J. Kiefer and J. Wolfowitz. Consistency of the maximum likelihood estimator in the presence of infinitely many incidental parameters. Ann. Math. Statist., 27(4):887–906, 1956.
232. J. Kiefer and J. Wolfowitz. The equivalence of two extremum problems. Canad. J. Math., 12:363–366, 1960.
233. C.P. Kitsos, D.M. Titterington, and B. Torsney. An optimal design problem in rhythmometry. Biometrics, 44:657–671, 1988.
234. N.P. Klepikov and S.N. Sokolov. Analysis and Planning of Experiments by the Method of Maximum Likelihood. Akademie-Verlag, Berlin, 1961.
235. S. Kotz, N. Balakrishnan, and N.L. Johnson. Continuous Multivariate Distributions, volume 1. Wiley, New York, 2nd edition, 2000.
236. S. Kotz, T. Kozubowski, and K. Podgorski. The Laplace Distribution and Generalizations: A Revisit with Applications to Communications, Economics, Engineering, and Finance. Birkhäuser, 2001.
237. E. Kpamegan and N. Flournoy. An optimizing up-and-down design. In A.C. Atkinson, B. Bogacka, and A. Zhigljavsky, editors, Optimum Design 2000, pages 211–224. Kluwer, Dordrecht, 2001.
238. E.P. Kpamegan. D-optimal design given a bivariate probit response function. In N. Flournoy, W.F. Rosenberger, and W.K. Wong, editors, New Developments and Applications in Experimental Design, volume 34 of IMS Lecture Notes – Monograph Series, pages 62–72. Institute of Mathematical Statistics, Hayward, CA, 1998.
239. A.R. Krommer and C.W. Ueberhuber. Computational Integration. SIAM, Philadelphia, 1998.
240. E. Kuhn and M. Lavielle. Maximum likelihood estimation in nonlinear mixed effects models. Comput. Stat. Data An., 49:1020–1038, 2005.
241. L.F. Lacey, O.N. Keene, J.F. Pritchard, and A. Bye. Common non-compartmental pharmacokinetic variables: Are they normally or log-normally distributed? J. Biopharm. Statist., 7(1):171–178, 1997.
242. T.L. Lai. Sequential analysis: some classical problems and new challenges. Statistica Sinica, 11(2):303–351, 2001.
243. T.L. Lai. Stochastic approximation. Ann. Statist., 31(2):391–406, 2003.
244. T.L. Lai and H. Robbins. Adaptive design in regression and control. Proc. Natl. Acad. Sci. USA, 75(2):586–587, 1978.
245. T.L. Lai and H. Robbins. Adaptive design and stochastic approximation. Ann. Statist., 7:1196–1221, 1979.
246. T.L. Lai and H. Robbins. Iterated least squares in multiperiod control. Adv. Appl. Math., 3(1):50–73, 1982.
247. T.L. Lai and C.Z. Wei. Least squares estimation in stochastic regression models, with application to identification and control of dynamic systems. Ann. Statist., 10:154–166, 1982.
248. P.J. Laurent. Approximation et Optimization. Hermann, Paris, 1972.
249. E. Läuter. Experimental design in a class of models. Math. Oper. Statist., Ser. Statist., 5:379–398, 1974.
250. M. Lavielle and F. Mentré. Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software. J. Pharmacokin. Pharmacodyn., 34(2):229–249, 2007.
251. L. Le Cam. Asymptotic Methods in Statistical Decision Theory. Springer, New York, 1986.
252. E.L. Lehmann and G. Casella. Theory of Point Estimation. Springer, New York, 2nd edition, 1998.
253. S. Leonov and A. Aliev. Optimal design for population PK/PD models. Tatra Mountains Mathematical Publications, 51:115–130, 2012.
254. max model and its application in clinical trials. J. Biopharm. Statist., 19(2):361– 385, 2009.
255. E. Lesaffre and G. Molenberghs. Multivariate probit analysis: A neglected procedure in medical statistics. Statist. Med., 10:1391–1403, 1991.
256. Z. Li, S.D. Durham, and N. Flournoy. An adaptive design for maximization of a contingent binary response. In N. Flournoy and W.F. Rosenberger, editors, Adaptive Designs, volume 25 of IMS Lecture Notes – Monograph Series, pages 139–157. Institute of Mathematical Statistics, Hayward, CA, 1995.
257. B.W. Lindgren. Statistical Theory. Chapman & Hall, London, 4th edition, 1993.
258. D.V. Lindley. On a measure of the information provided by an experiment. Ann. Math. Statist., 27:986–1005, 1956.
259. M.J. Lindstrom and D.M. Bates. Nonlinear mixed effects models for repeated measures data. Biometrics, 46:673–687, 1990.
260. R.C. Littell, G.A. Milliken, W.W. Stroup, R.D. Wolfinger, and O. Sch-abenberger. SAS for Mixed Models. SAS Institute, Cary, NC, 2006.
261. J. López-Fidalgo and W.K. Wong. Design issues for Michaelis-Menten model. J. Theor. Biol., 215:1–11, 2002.
262. J.R. Magnus and H. Neudecker. Matrix Differential Calculus with Applications in Statistics and Econometrics. Wiley, New York, 1988.
263. A. Mallet. A maximum likelihood estimation method for random coefficient regression models. Biometrika, 41:1015–1023, 1986.
264. M.B. Malyutov. Lower bounds for an average number of sequentially designed experiments. In K. Ito and Yu.V. Prokhorov, editors, Probability Theory and Mathematical Statistics, pages 419–434. Springer, Berlin, 1982.
265. M.B. Malyutov. On asymptotic properties and application of IRGNA-estimates for parameters of generalized regression models. In Stochastic Processes and Applications, pages 144–165. Moscow (in Russian), 1982.
266. M.B. Malyutov. Design and analysis in generalized regression model. In V.V. Fedorov and H. Läuter, editors, Model-Oriented Data Analysis, pages 72–76. Springer, Berlin, 1988.
267. M. Marcus and H. Minc. A Survey of Matrix Theory and Matrix Inequalities. Dover, New York, 1992.
268. R.J. Martin. Spatial experimental design. In S. Ghosh and C.R. Rao, editors, Design and Analysis of Experiments, volume 13 of Handbook of Statistics, pages 477–514. Elsevier, North Holland, 1996.
269. R. Martín-Martín, L. Rodríguez-Aragón, and B. Torsney. Multiplicative algorithm for computing D-optimum designs for pVT measurements. Chemometrics Intell. Lab. Syst., 111(1):20–27, 2012.
270. B. Matérn. Spatial Variation. Springer, Berlin, 1986.
271. T. Mathew and B.K. Sinha. Optimal designs for binary data under logistic regression. J. Statist. Plann. Inf., 93:295–307, 2001.
272. G.P. McCabe. Optimal designs for binary data under logistic regression. Technometrics, 26(2):137–144, 1984.
273. D.L. McLeish and D. Tosh. Sequential designs in bioassay. Biometrics, 46:103–116, 1990.
274. G. Megreditchan. L’optimization des reseaux d’observation des champs meteorologiques. La Meterologie, 6:51–66, 1979.
275. V.B. Melas. Functional Approach to Optimal Experimental Design, volume 184 of Lecture Notes in Statistics. Springer, New York, 2006.
276. F. Mentré, S. Duffull, I. Gueorguieva, A. Hooker, S. Leonov, K. Ogungbenro, and S. Retout. Software for optimal design in population pharmacokinetics and pharmacodynamics: A comparison. In Abstracts of the Annual Meeting of the Population Approach Group in Europe. ISSN 1871-6032. PAGE http://www.page-meeting.org/?abstract=1179, 2007.
277. F. Mentré, A. Mallet, and D. Baccar. Optimal design in random-effects regression models. Biometrika, 84(2):429–442, 1997.
278. F. Mentré, Y. Merlé, J. Van Bree, A. Mallet, and J.-L. Steimer. Sparse-sampling optimal designs in pharmacokinetics and toxicokinetics. Drug Inf. J., 29:997–1019, 1995.
279. F. Mentré, J. Nyberg, K. Ogungbenro, S. Leonov, A. Aliev, S. Duffull, C. Bazzoli, and A. Hooker. Comparison of results of the different software for design evaluation in population pharmacokinetics and pharmacodynamics. In Abstracts of the Annual Meeting of the Population Approach Group in Europe (PAGE). ISSN 1871-6032. PAGE http://www.page-meeting.org/default.asp?abstract=2066, 2011.
280. Y. Merlé and M. Todd. Impact of pharmacokineticpharmacodynamic model linearization on the accuracy of population information matrix and optimal design. J. Pharmacokin. Pharmacodyn., 28(4):363–388, 2001.
281. R.K. Meyer and C.J. Nachtsheim. Constructing exact d-optimal experimental designs by simulated annealing. Amer. J. Math. Manage. Sci., 8:329–359, 1988.
282. C.A. Micchelli and G. Wahba. Design problem for optimal surface interpolation. In Z. Ziegler, editor, Approximation Theory and Applications, pages 329–348. Academic Press, New York, 1996.
283. T. Mielke and R. Schwabe. Some considerations on the Fisher information in nonlinear mixed effects models. In A. Giovagnoli, A.C. Atkinson, and B. Torsney, editors, mODa 9 – Advances in Model-Oriented Design and Analysis, pages 129–136. Physica-Verlag/Springer, Berlin, 2010.
284. F. Miller, O. Guilbaud, and Dette H. Optimal designs for estimating the interesting part of a dose-effect curve. J. Biopharm. Statist., 17:1097– 1115, 2007.
285. S. Minkin. Optimal designs for binary data. J. Am. Statist. Assoc., 82:1098–1103, 1987.
286. T.J. Mitchell. An algorithm for construction of D-optimal experimental designs. Technometrics, 16:203–211, 1974.
287. G. Molenberghs and G. Verbeke. Models for Discrete Longitudinal Data. Springer, New York, 2005.
288. MONOLIX. http://www.lixoft. net/monolix/overview/. Lixoft, 2011.
289. M. Morris. Design of Experiments. An Introduction Based on Linear Models. Chapman & Hall/CRC, Boca Raton, FL, 2010.
290. R. Muirhead. Aspects of Multivariate Statistical Theory. Wiley, New York, 1982.
291. W.G. Müller. Collecting Spatial Data (Optimum Design of Experiments for Random Fields). Springer, Berlin, 2007.
292. P.A. Murtaugh and L.D. Fisher. Bivariate binary models of efficacy and toxicity in dose-ranging trials. Commun. Statist. Theory Meth., 19:2003–2020, 1990.
293. C.J. Nachtsheim. Tools for computer-aided design of experiments. J. Qual. Technol., 19:132–160, 1987.
294. J.R. Nedelman and E. Gibiansky. The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics. J. Pharm. Sciences, 85(8):884–886, 1996.
295. A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, T.J. Layden, and A.S. Perelson. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy. Science, 282:103–107, 1998.
296. J. Nyberg, S. Ueckert, E. Strömberg, M.O. Karlsson, and A.C. Hooker. PopED, version 2.12. In http://poped. sourceforge. net, 2011.
297. K. Ogungbenro and L. Aarons. An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments. J. Biopharm. Statist., 19(1):174–189, 2009.
298. J. O’Quigley. Dose-finding designs using continual reassessment method. In J. Crowley, editor, Handbook of Statistics in Clinical Oncology, pages 35–72. Marcel Dekker, New York, 2001.
299. J. O’Quigley and M. Conaway. Continual reassessment and related dose-finding designs. Statist. Sci., 25(2):245–257, 2010.
300. J. O’Quigley, M. Hughes, and T. Fenton. Dose finding designs for HIV studies. Biometrics, 57:1018–1029, 2001.
301. J. O’Quigley, M. Pepe, and L. Fisher. Continual reassessment method: A practical design for phase I clinical trials in cancer. Biometrics, 46:33– 48, 1990.
302. A.P. Oron and P.D. Hoff. The k-in-a-row up-and-down design, revisited. Statist. Med., 28(13):1805–1820, 2009.
303. R.V. Overgaard, N. Jonsson, C.W. Tornoe, and H. Madsen. Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithm. J. Pharmacokinet. Pharmacodyn., 32(1):85–107, 2005.
304. C.R. Palmer and W.F. Rosenberger. Ethics and practice: Alternative designs for phase III randomized clinical trials. Controlled Clinical Trials, 20:172–186, 1999.
305. M. Patan and B. Bogacka. Efficient sampling windows for parameter estimation in mixed effects models. In J. López-Fidalgo, J.M. Rodriguez-Diaz, and B. Torsney, editors, mODa 8 – Advances in Model-Oriented Design and Analysis, pages 147–155. Physica-Verlag, Heidelberg, 2007.
306. A. Pázman. Foundations of Optimum Experimental Design. Reidel, Dordrecht, 1986.
307. A. Pázman. Nonlinear Statistical Models. Kluwer, Dordrecht, 1993.
308. U. Picchini, S. Ditlevsen, and A. De Gaetano. Modeling the euglycemic hyperinsulinemic clamp by stochastic differential equations. J. Math. Biol., 53:771–796, 2006.
309. J. Pilz. Bayesian Estimation and Experimental Design in Linear Regression Models. Wiley, New York, 1991.
310. J.C. Pinheiro and D.M. Bates. Approximations to the log-likelihood function in the nonlinear mixed-effects model. J. Comp. Graph. Stat., 4:1235, 1995.
311. J.C. Pinheiro and D.M. Bates. Mixed Effects Models in S and S-Plus. Springer, New York, 2002.
312. S.J. Pocock. Clinical Trials. Wiley, Chichester, 1983.
313. B.T. Polyak. New method of stochastic approximation type. Automat. Remote Control, 51:937–946, 1990.
314. B.T. Polyak and A.B. Juditsky. Acceleration of stochastic approximation by averaging. SIAM J. Control Optim., 30:838–855, 1992.
315. J.W. Pratt, H. Raiffa, and R. Schlaifer. Introduction to Statistical Decision Theory. MIT Press, Cambridge, MA, 1995.
316. L. Pronzato. Adaptive optimization and D-optimum experimental design. Ann. Statist., 28(6):1743–1761, 2000.
317. L. Pronzato. Optimal experimental design and some related control problems. Automatica, 44:303–325, 2008.
318. L. Pronzato. Penalized optimal designs for dose-finding. J. Statist. Plann. Inf., 140(1):283–296, 2010.
319. L. Pronzato and A. Pázman. Nonlinear experimental design based on the distribution of estimators. J. Statist. Plann. Inf., 33:385–402, 1992.
320. L. Pronzato and A. Pázman. Second-order approximation of the entropy in nonlinear least-squares estimation. Kybernetika, 30(2):187–198, 1994.
321. L. Pronzato and A. Pázman. Using densities of estimators to compare pharmacokinetic experiments. Comput. Biol. Med., 31(3):179–195, 2001.
322. L. Pronzato and A. Pázman. Design of Experiments in Nonlinear Models: Asymptotic Normality, Optimality Criteria and Small-Sample Properties, volume 212 of Lecture Notes in Statistics. Springer, New York, 2013.
323. L. Pronzato and E. Walter. Robust experiment design via stochastic approximation. Math. Biosci., 75:103–120, 1985.
324. L. Pronzato and E. Walter. Robust experiment design via maximin optimization. Math. Biosci., 89:161–176, 1988.
325. L. Pronzato, H. Wynn, and A. Zhigljavsky. Dynamical Search: Applications of Dynamical Systems in Search and Optimization. Chapman & Hall/CRC, Boca Raton, FL, 2000.
326. M.A. Proschan, K.K.G. Lan, and J.T. Wittes. Statistical Monitoring of Clinical Trials. A Unified Approach. Springer, New York, 2006.
327. B.N. Pshenichnyi. Necessary Conditions for an Extremum. Marcel Dekker, New York, 1971.
328. F. Pukelsheim. Optimal Design of Experiments. Wiley, New York, 1993.
329. F. Pukelsheim and B. Torsney. Optimal weights for experimental designs on linearly independent support points. Ann. Statist., 19:1614–1625, 1991.
330. R.D. Purves. Optmimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). J. Pharmacokinet. Biopharm., 20(3):211–226, 1992.
331. H.S. Rabie and N. Flournoy. Optimal designs for contingent responses models. In A. Di Bucchianico, H. Läuter, and H. Wynn, editors, mODa 7 – Advances in Model-Oriented Design and Analysis, pages 133–142. Physica-Verlag, Heidelberg, 2004.
332. A. Racine-Poon. A Bayesian approach to non-linear random effects models. Biometrics, 41:1015–1024, 1985.
333. C.R. Rao. The theory of least squares when the parameters are stochastic and its application to the analysis of growth curves. Biometrika, 52 (3/4):447–458, 1965.
334. C.R. Rao. Linear Statistical Inference and Its Applications. Wiley, New York, 2nd edition, 1973.
335. D. Rasch, J. Pilz, L.R. Verdooren, and A. Gebhardt. Optimal Experimental Design with R. Chapman & Hall/CRC, Boca Raton, FL, 2011.
336. D.A. Ratkowsky. Nonlinear Regression Modeling. Marcel Dekker, New York, 1983.
337. D.A. Ratkowsky. Handbook of Nonlinear Regression Models. Marcel Dekker, New York, 1990.
338. D.A. Ratkowsky and T.J. Reedy. Choosing non-linear parameters in the four-parameter logistic model for radioligand and related assays. Biometrics, 42:575–582, 1986.
339. S. Retout, S.B. Duffull, and F. Mentré. Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs. Comp. Meth. Progr. Biomed., 65:141–151, 2001.
340. S. Retout and F. Mentré. Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics. J. Biopharm. Statist., 13(2):209–227, 2003.
341. H. Robbins and S. Monro. A stochastic approximation method. Ann. Math. Statist., 22:400–407, 1951.
342. W.F. Rosenberger and L.M. Haines. Competing designs for phase I clinical trials: A review. Statist. Med., 21:2757–2770, 2002.
343. W.F. Rosenberger and J.M. Hughes-Oliver. Inference from a sequential design: Proof of conjecture by Ford and Silvey. Statist. Prob. Lett., 44:177–180, 1999.
344. W.F. Rosenberger, N. Stallard, A. Ivanova, C. Harper, and M. Ricks. Optimal adaptive designs for binary response trials. Biometrics, 57:909– 913, 2001.
345. D. Ruppert. Efficient estimators from a slowly convergent Robbins-Monro procedure. Technical Report 781, School of Operations Research and Industrial Engineering. Cornell University, Ithaca, NY, 1988.
346. J. Sacks. Asymptotic distribution of stochastic approximation procedures. Ann. Math. Statist., 29:373–405, 1958.
347. J. Sacks and D. Ylvisacker. Designs for regression problems with correlated errors. Ann. Math. Statist., 37:66–89, 1966.
348. J. Sacks and D. Ylvisacker. Designs for regression problems with correlated errors, many parameters. Ann. Math. Statist., 39:49–69, 1968.
349. J. Sacks and D. Ylvisacker. Designs for regression problems with correlated errors, III. Ann. Math. Statist., 39:2057–2074, 1968.
350. T. Schmelter. Considerations on group-wise identical designs for linear mixed models. J. Statist. Plann. Inf., 137:4003–4010, 2007.
351. T. Schmelter. The optimality of single-group designs for certain mixed models. Metrika, 65:183–193, 2007.
352. T. Schmelter, N. Benda, and R. Schwabe. Some curiosities in optimal designs for random slopes. In J. López-Fidalgo, J.M. Rodriguez-Diaz, and B. Torsney, editors, mODa 8 – Advances in Model-Oriented Design and Analysis, pages 189–195. Physica-Verlag, Heidelberg, 2007.
353. R. Schwabe. Optimum Designs for Multi-Factor Models, volume 113 of Lecture Notes in Statistics. Springer, New York, 1996.
354. P. Sebastiani and Wynn H. Maximum entropy sampling and optimal Bayesian experimental design. J. Royal Statist. Soc. B, 62:145–157, 2000.
355. G.A.F. Seber. Multivariate Observations. Wiley, New York., 1984.
356. G.A.F. Seber. A Matrix Handbook for Statisticians. Wiley, Hoboken, NJ, 2008.
357. G.A.F. Seber and C.I. Wild. Nonlinear Regression. Wiley, New York., 1989.
358. M. Shewry and H. Wynn. Maximum entropy sampling. J. Appl. Stat., 14:165–169, 1987.
359. J. Shu and J. O’Quigley. Dose-escalation designs in oncology: ADEPT and the CRM. Statist. Med., 27:5345–5353, 2008.
360. S.D. Silvey. Optimal Design. Chapman & Hall, London, 1980.
361. S.D. Silvey and D.M. Titterington. A geometric approach to optimal design theory. Biometrika, 60(1):21–32, 1973.
362. S.D. Silvey, D.M. Titterington, and B. Torsney. An algorithm for optimal designs on a finite design space. Comm. Statist. Theory Methods, 14:1379–1389, 1978.
363. R.R. Sitter. Robust designs for binary data. Biometrics, 48:1145–1155, 1992.
364. K. Smith. On the standard deviations of adjusted and interpolated values of an observed polynomial function and its constants and the guidance they give towards a proper choice of the distribution of observations. Biometrika, 12:1–85, 1918.
365. S.N. Sokolov. Continuous planning of regression experiments. Theory Probab. Appl., 8:89–96, 1963.
366. S.N. Sokolov. Continuous planning of regression experiments. II. Theory Probab. Appl., 8:298–304, 1963.
367. E. Spjotvoll. Random coefficients regression models. A Review. Statistics, 8:69–93, 1977.
368. S.M. Stigler. Gergonne’s 1815 paper on the design and analysis of polynomial regression experiments. Historia Mathematica, 1(4):431–439, 1974.
369. J.R. Stroud, P. Müller, and G.L. Rosner. Optimal sampling times in population pharmacokinetic studies. Appl. Statist., 50:345–359, 2001.
370. M. Stylianou and N. Flournoy. Dose finding using the biased coin up-and-down design and isotonic regression. Biometrics, 58(1):171–177, 2002.
371. M.A. Tanner. Tools for Statistical Inference. Methods for the Exploration of Posterior Distributions and Likelihood Functions. Springer, New York, 1996.
372. P. Thall, R.E. Millikan, P. Mueller, and S.-J. Lee. Dose-finding with two agents in phase I oncology trials. Biometrics, 59:487–496, 2003.
373. P. Thall and K. Russell. A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials. Biometrics, 54:251–264, 1998.
374. P.F. Thall and J.D. Cook. Dose-finding based on efficacy-toxicity trade-offs. Biometrics, 60:684–693, 2004.
375. D.M. Titterington. Algorithms for computing D-optimal design on finite design spaces. In Proceedings of the 1976 Conference on Information Science and Systems, pages 213–216. John Hopkins University, Baltimore, MD, 1976.
376. D.M. Titterington. Estimation of correlation coefficients by ellipsoidal trimming. J. Appl. Stat., 27:227–234, 1978.
377. C.W. Tornoe, J.L. Jacobsen, and H. Madsen. Grey-box pharmacokinetic/pharmacodynamic modelling of a euglycaemic clamp study. J. Math. Biol., 48:591–604, 2004.
378. C.W. Tornoe, J.L. Jacobsen, O. Pedersen, T. Hansen, and H. Madsen. Grey-box modelling of pharmacokinetic/pharmacodynamic systems. J. Pharmacokinet. Pharmacodyn., 31(5):401–417, 2004.
379. B. Torsney. Contribution to discussion of a paper by Dempster, Laird and Rubin. J. Roy. Statist. Soc. Ser. B, 39:22–27, 1977.
380. B. Torsney. A moment inequality and monotonicity of an algorithm. In K.O. Kortanek and A.V. Fiacco, editors, Proceedings of the International Symposium on Semi-Infinite Programming and Applications, Lecture Notes in Economics and Mathematical Systems, pages 249–260. Springer, Berlin, 1983.
381. B. Torsney. W-iterations and ripples therefrom. In L. Pronzato and A.A. Zhigljavsky, editors, Optimal Design and Related Areas in Optimization and Statistics, volume 28 of Springer Optimization and Its Applications, pages 1–12. Springer, New York, 2009.
382. B. Torsney and S. Mandal. Two classes of multiplicative algorithms for constructing optimizing distributions. Comp. Statist. Data Analysis, 51(3):1591–1601, 2006.
383. B. Torsney and R. Martín-Martín. Multiplicative algorithms for computing optimum designs. J. Statist. Plann. Inf., 139:3947–3961, 2006.
384. B. Torsney and A.K. Musrati. On the construction of optimal designs with applications to binary response and to weighted regression models. In W.G. Müller, H.P. Wynn, and A.A. Zhigljavsky, editors, Model-Oriented Data Analysis, pages 37–52. Physica-Verlag, Heidelberg, 1993.
385. J.Y. Tsay. On the sequential construction of D-optimal designs. J. Am. Stat. Assoc., 71(355):671–674, 1976.
386. G. Verbeke and G. Molenberghs. Linear Mixed Models for Longitudinal Data. Springer, New York, 2000.
387. G. von Békésy. A new audiometer. Archives of Otolaryngology, 35:411– 422, 1947.
388. E.F. Vonesh and V.M. Chinchilli. Linear and Nonlinear Models for the Analysis of Repeated Measurements. Marcel Dekker, New York, 1997.
389. G. Wahba. Spline Models for Observational Data. SIAM, Philadelphia, 1990.
390. J.C. Wakefield. The Bayesian approach to population pharmacokinetic models. J. Am. Statist. Assoc., 91:134–140, 1996.
391. A. Wald. On the efficient design of statistical investigations. Ann. Math. Statist., 14:134–140, 1943.
392. S. Wald. Spline functions in data analysis. Technometrics, 16(1):1–11, 1974.
393. S.J. Wang, H.M. Hung, and R.T. O’Neill. Paradigms for adaptive statistical information designs: Practical experiences and strategies. Statist. Med., 31:3011–3023, 2012.
394. W. Wang, R.F. Woolson, and W.R. Clarke. Estimating and testing treatment effects on two binary endpoints and association between endpoints in clinical trial. Comm. Statist. Simul. Comp., 34:751–769, 2005.
395. Y. Wang. Derivation of various NONMEM estimation methods. J. Pharmacokin. Pharmacodyn., 34(5):575–593, 2007.
396. G.B. Wetherill. Sequential estimation of quantal response curves (with discussion). J. Royal Stat. Soc. Ser.B, 25(1):1–48, 1963.
397. G.B. Wetherill and K.D. Glazebrook. Sequential Methods in Statistics. Chapman & Hall, London, 1986.
398. L.V. White. The optimal design of experiments for estimation in nonlinear model. PhD thesis, University of London, 1975.
399. L.V. White. An extension of the general equivalence theorem to nonlinear models. Biometrika, 60(2):345–348, 1993.
400. J. Whitehead, S. Patterson, D. Webber, S. Francis, and Y. Zhou. Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers. Biostatistics, 2:47–61, 2001.
401. J. Whitehead and D. Williamson. An evaluation of Bayesian decision procedures for dose-finding studies. J. Biopharm. Statist., 8:445–467, 1998.
402. J. Whitehead, Y. Zhou, J. Stevens, and G. Blakey. An evaluation of a Bayesian method of dose escalation based on bivariate binary responses. J. Biopharm. Statist., 14:969–983, 2004.
403. J. Whitehead, Y. Zhou, J. Stevens, G. Blakey, J. Price, and J. Leadbet-ter. Bayesian decision procedures for dose-escalation based on evidence of undesarable events and therapeutic benefit. Statist. Med., 25:37–53, 2006.
404. E.T. Whittaker and G. Robinson. Calculus of Observations: A Treatise on Numerical Mathematics. Dover, New York, 4th edition, 1967.
405. P. Whittle. Some general points in the theory of optimal experimental design. J. Roy. Statist. Soc. Ser. B, 35:123–130, 1973.
406. R.D. Wolfinger. Laplace’s approximation for nonlinear mixed models. Biometrika, 80:791–795, 1993.
407. H. Wolkowicz, R. Saigal, and L. Vandenberghe. Handbook of Semidef-inite Programming: Theory, Algorithms, and Applications. Springer, New York, 2000.
408. C.F. Wu. Some algorithmic aspects of the theory of optimal designs. Ann. Statist., 6(6):1286–1301, 1978.
409. C.F. Wu and Wynn H.P. The convergence of general step-length algorithms for regular optimum design criteria. Ann. Statist., 6(6):1273– 1283, 1978.
410. C.F.J. Wu. Asymptotic theory of nonlinear least squares estimation. Ann. Statist., 9(3):501–513, 1981.
411. C.F.J. Wu. Asymptotic inference from sequential design in a nonlinear situation. Biometrika, 72(3):553–558, 1985.
412. C.F.J. Wu. Efficient sequential designs with binary data. J. Am. Statist. Assoc., 80:974–984, 1985.
413. C.F.J. Wu. Optimal design for percentile estimation of a quantal-response curve. In Y. Dodge, V.V. Fedorov, and H.P. Wynn, editors, Optimal Design and Analysis of Experiments, pages 213–223. Elsevier, North Holland, 1988.
414. C.F.J. Wu and M. Hamada. Experiments: Planning, Analysis, and Parameter Design Optimization. Wiley, New York, 2002.
415. Y. Wu, V.V. Fedorov, and K.J. Propert. Optimal design for dose response using beta distributed responses. J. Biopharm. Statist., 15(5):753–771, 2005.
416. H.P. Wynn. The sequential generation of D-optimal experimental designs. Ann. Math. Statist., 41:1655–1664, 1970.
417. H.P. Wynn. Results in the theory and construction of D-optimum experimental designs. J. Roy. Statist. Soc. B, 34:133–147, 1972.
418. H.P. Wynn. Jack Kiefer’s contribution to experimental design. Ann. Statist., 12:416–423, 1984.
419. M. Yang. On the de la Garza phenomenon. Ann. Statist., 38(4):2499– 2524, 2010.
420. K.C. Yeh and K.C. Kwan. A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J. Pharmacokinet. Biopharm., 6(1):79–98, 1978.
421. Z. Ying and C.F.J. Wu. An asymptotical theory of sequential designs based on maximum likelihood recursions. Statistica Sinica, 7:75–91, 1997.
422. T.J. Ypma. Historical development of the Newton-Raphson method. SIAM Review, 37:531–551, 1995.
423. Y. Yu. Monotonic convergence of a general algorithm for computing optimal designs. Ann. Statist., 38(3):1593–1606, 2010.
424. S. Zacks. Adaptive designs for parametric models. In S. Ghosh and C.R. Rao, editors, Design and Analysis of Experiments. Handbook of Statistics, volume 13, pages 151–180. Elsevier, Amsterdam, 1996.
425. S. Zacks. Stage-Wise Adaptive Designs. Wiley, Hoboken, NJ, 2009.
426. W. Zhu and W.K. Wong. Multiple-objective designs in a dose-response experiment. J. Biopharm. Statist., 10(1):1–14, 2001.